340B INDUSTRY LEADER SPOTLIGHT

Kelly Kolker, President, 340B Solutions, CPS

Kelly Kolker

Q: Where did you grow up?

Born and raised in the great state of Iowa, and I still live here.  It is a fantastic place to raise a family.

Q: Where did you go to college/graduate school?

Clarke University for undergrad (Chemistry); The University of Iowa for Pharmacy School; University of Dubuque for MBA.

Q:

Read More »

340B INDUSTRY LEADER SPOTLIGHT

Ben Kelly, RPh, MBA, VP of Pharmacy Operations, Maxor Pharmacy Management

Ben Kelly

Q: Where did you grow up?

I grew up in Winter Garden, FL just outside of Orlando where I still reside. My kids go to the same high school my wife and I attended.

Q: Where did you go to college/graduate school?

I received my pharmacy degree from the University of Georgia. My MBA was through Crummer

Read More »
Industry Insights Logo

Is Your Technology a Triple Threat That Boosts Your Mission?

SPONSORED CONTENT

When people consider technology’s role in adapting to pandemic-constrained life, many begrudgingly think about endless hours spent on videoconferences. Yet, pandemic-infused technological innovations also altered our lives in other ways, big and small. For instance, I’ll never go back to

Read More »

Minnesota Imposes Nation’s First 340B Covered Entity Reporting Requirements

Tim Walz
Minnesota became the first state to impose 340B reporting requirements after Gov. Tim Walz (D) signed legislation in late May.

Minnesota health care providers were shocked to learn that a bill signed into law in late May made their state the first to require all 340B covered entities to report their total 340B drug acquisition costs and payments.

The first

Read More »

340B Stakeholders Testify on Conn. Governor’s First-of-Its-Kind Multi-Pronged 340B Legislation

Connecticut state capitol dome
Connecticut lawmakers heard testimony yesterday on Gov. Ned Lamont’s (D) bill addressing hospitals' 340B revenue, pharma restrictions on 340B contract pharmacy use, and PBM discrimination against 340B entities.

Connecticut 340B stakeholders testified at a state legislative hearing Monday on Gov. Ned Lamont’s (D) comprehensive bill to require hospital reporting on 340B revenue, prohibit drug maker restrictions on 340B contract pharmacy use, and prohibit pharmacy benefit manager discrimination against

Read More »

News Alert

Some Provider Groups Slam NACHC and PhRMA’s 340B Plan, Others Say They’re Studying it

NACHC P&I 2023 speaker at podium
Lt. Cmdr. Emeka Egwim (left), Director of HRSA's Office of Pharmacy Affairs, spoke this morning on 340B Day at NACHC's annual Policy & Issues Forum in Washington, D.C.

A large HIV/AIDS health care group, a Democratic 340B provider ally in Congress, and three national hospital groups lambasted community health centers and drug makers’ historic announcement yesterday that they are working together to remake the 340B program. Other 340B

Read More »

News Alert

340B Raised Often During Senate Hearing on Community Health Centers

Sen. Bill Cassidy pictured at a hearing
Sen. Bill Cassidy (R-La.) asked a witness during a hearing if she was open to 340B reforms to ensure that 340B savings “are not going to build a chandelier in a hospital et cetera.”

The 340B program—and whether it needs change, protection, or both—came up often today during a U.S. Senate hearing on federal funding of community health centers.

The bulk of health centers’ federal grant funding—about $5.8 billion annually from the U.S. Health

Read More »

Health Centers and PhRMA Co-Developing 340B Policies, Hospital Group Says

NACHC and PhRMA wordmarks
NACHC and PhRMA are jointly developing 340B policy proposals for Congress to consider, hospital group 340B Health says.

Associations representing community health centers and brand drug manufacturers are jointly developing 340B policy proposals for Congress to consider, hospital group 340B Health told its members yesterday.

The National Association of Community Health Centers said yesterday that it had no

Read More »

The Day After: Stakeholders Take Stock of Third Circuit Court’s 340B Contract Pharmacy Opinion

United States Third Circuit Court building entrance
Drug makers "need not help [covered entities] maximize their 340B profits," a federal appeals court in Philadelphia said yesterday in holding that three manufacturers' restrictions on delivery to contract pharmacies do not violate the 340B statute.

Covered entities may still use the 340B program under drug manufacturers’ conditions on the use of contract pharmacies, and while they “cannot squeeze as much revenue out of it as they once could, drug makers need not help them maximize

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live